Literature DB >> 16034713

Interleukin-6 concentrations in the placenta and blood in normal pregnancies and preeclampsia.

M Hayashi1, Y Ueda, T Ohkura, N Inaba.   

Abstract

AIM: To evaluate whether IL-6 concentrations in the placenta and blood from women with preeclampsia differed from those in normal pregnancies.
METHODS: This study involved 41 pregnant women carrying single fetuses. Of these pregnancies, 23 were normal pregnant and 18 were preeclamptic patients. The average gestational age at entry was 37-38 weeks of gestation. Blood was collected before the onset of labor. Serum was separated and stored at -20 degrees C. A tissue segment of the placenta was cut and chilled in liquid nitrogen immediately after delivery and stored at -80 degrees C. The frozen tissue was added to phosphate-buffered saline and fully homogenized. After centrifugation, the separated supernatant was stored at -80 degrees C. IL-6 levels in separated serum and IL-6 and total protein (TP) levels in separated supernatant were measured. The presence of IL-6 in the placenta was evaluated by immunohistochemistry in five preeclamptic and five normal pregnant patients.
RESULTS: Neither IL-6/TP levels in the placenta nor IL-6 levels in blood differed significantly between the two groups. IL-6 immunostaining on trophoblastic cells in the placenta was weak in one and absent in four in normal pregnancies, and absent in all patients with preeclampsia. There was no strong immunostaining for IL-6 in preeclampsia by immunohistochemistry.
CONCLUSIONS: Our findings suggest that IL-6 in the placenta and blood does not play a significant role in the induction of an immunologic imbalance, which may contribute to the etiological mechanism leading to preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16034713     DOI: 10.1055/s-2005-870231

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  5 in total

1.  Sleep Disturbances and Modulations in Inflammation: Implications for Pregnancy Health.

Authors:  Michele L Okun
Journal:  Soc Personal Psychol Compass       Date:  2019-04-11

2.  Role of IL-6 -174(G/C) promoter polymorphism in the etiology of early-onset preeclampsia.

Authors:  Sabnavis Sowmya; Aruna Ramaiah; Pratibha Nallari; Akka Jyothy; Ananthapur Venkateshwari
Journal:  Inflamm Res       Date:  2015-04-28       Impact factor: 4.575

Review 3.  How disturbed sleep may be a risk factor for adverse pregnancy outcomes.

Authors:  Michele L Okun; James M Roberts; Anna L Marsland; Martica Hall
Journal:  Obstet Gynecol Surv       Date:  2009-04       Impact factor: 2.347

4.  Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells.

Authors:  Charles J Lockwood; Chih-Feng Yen; Murat Basar; Umit A Kayisli; Maritza Martel; Irina Buhimschi; Catalin Buhimschi; S Joseph Huang; Graciela Krikun; Frederick Schatz
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

5.  Oxidative and Inflammatory Imbalance in Placenta and Kidney of sFlt1-Induced Early-Onset Preeclampsia Rat Model.

Authors:  Álvaro Santana-Garrido; Claudia Reyes-Goya; Pablo Espinosa-Martín; Luis Sobrevia; Luis M Beltrán; Carmen M Vázquez; Alfonso Mate
Journal:  Antioxidants (Basel)       Date:  2022-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.